US health panel weighs Merck Covid-19 pill authorisation

US health panel weighs Merck Covid-19 pill authorisation - Hello loyal readers FeedGoogle, In the article you are reading this time with the title US health panel weighs Merck Covid-19 pill authorisation, We have prepared this article well for you to read and take information in it. hopefully the contents of the post Article World, what we write you can understand. Alright, happy reading.

Molnupiravir, already authorised in Britain, has been shown to reduce the rate of hospitalisations and deaths among high-risk Covid patients when taken soon after infection. —Merck & Co Inc/Handout via Reuters Follow us on Instagram and subscribe to our Telegram channel for the latest updates. WASHINGTON, Dec 1 — A panel of health experts appointed by the US government was mulling yesterday whether to endorse Merck’s Covid pill, a new form of treatment that is easy to administer and could prove more able to withstand variants, including Omicron.Molnupiravir, already authorised in Britain, has been shown to reduce the rate of hospitalisations and deaths among high-risk Covid patients when taken soon after infection.Accordingly, Merck — known as MSD outside the United States and Canada — is seeking an emergency use authorisation (EUA) for non-hospitalised, high-risk people wit…